Everest Medicines Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Oct '25 Oct 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	17,302	15,592	6,698	5,375	10,326	19,851	Upgrade
Market Cap Growth	113.90%	132.78%	24.63%	-47.95%	-47.98%	-	Upgrade
Enterprise Value	16,370	13,630	4,306	3,712	6,099	22,544	Upgrade
Last Close Price	48.98	48.40	20.90	17.38	34.80	67.70	Upgrade
PS Ratio	18.55	20.73	48.28	371.66	155778.93	-	Upgrade
PB Ratio	4.02	3.60	1.22	0.84	1.43	2.44	Upgrade
P/TBV Ratio	9.37	8.06	2.49	1.45	2.46	3.46	Upgrade
EV/Sales Ratio	17.55	18.12	31.04	256.65	92015.48	-	Upgrade
Debt / Equity Ratio	0.19	0.14	0.11	0.10	0.09	0.07	Upgrade
Asset Turnover	-	0.13	0.02	0.00	0	-	Upgrade
Inventory Turnover	-	10.77	2.25	0.77	-	-	Upgrade
Quick Ratio	5.36	2.51	7.55	3.84	9.84	24.04	Upgrade
Current Ratio	5.46	2.54	7.63	3.92	9.95	24.06	Upgrade
Return on Equity (ROE)	-	-23.04%	-15.90%	-4.28%	-15.84%	-189.24%	Upgrade
Return on Assets (ROA)	-	-9.09%	-8.59%	-13.24%	-9.29%	-8.94%	Upgrade
Return on Capital (ROIC)	-	-9.60%	-9.10%	-13.94%	-9.56%	-9.31%	Upgrade
Earnings Yield	-4.17%	-7.11%	-13.89%	-5.20%	-11.99%	-33.85%	Upgrade
FCF Yield	-3.09%	-5.08%	-14.58%	-31.80%	-9.98%	-2.88%	Upgrade
Buyback Yield / Dilution	-0.25%	-2.51%	-5.18%	-1.49%	-243.61%	-1532.82%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.